Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Obstructive Sleep ApneaHypoxiaInsulin Resistance

Interventions

DEVICE

Continuous Positive Airway Pressure

CPAP is a noninvasive treatment for sleep apnea

Trial Locations (1)

University of California San Francisco, San Francisco

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, San Francisco

OTHER

NCT03695315 - Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia | Biotech Hunter | Biotech Hunter